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Mental health problems such as affective disorders, anxiety disorders, and psychotic disorders are not just diseases caused by psychological stressors added to genetic vulnerability, but rather full-body, inflammatory conditions related to the immune state \[[@CR1]--[@CR4]\]. In this light, the role of the microbiome, 100 trillion or so organisms that provide a barrier and a profound effect on our immune regulatory function, most notably in the large intestine \[[@CR5]\], becomes immensely important. The state of our microbiome affects not only diseases of the gut but also autoimmune disease, obesity \[[@CR6], [@CR7]\], and even how well the liver metabolizes alcohol \[[@CR8]\]. While every person's microbiome is unique, generally healthy people share certain species, diversity, and abundance. It is clear that the microbiomes of humans living in the developed world are far different from those of hunter-gatherers living more as our ancestors did \[[@CR9]\]. Are these observed differences in microbiota a surrogate marker for modern pressures exerted on humans? The available evidence would suggest that microbiota and mental health be viewed through the lens of physiological anthropology in the context of evolutionary medicine. Researchers have taken these findings to explore the impact of the microbiome on mental health \[[@CR10]\].

The gut-brain connection hinges on how the microbiome influences the hypothalamic-adrenal-pituitary axis in a similar way to psychological stress, with pathogenic species of bacteria interacting with the immune and endocrine systems to create an inflammatory cascade with an increase in sympathetic reactivity \[[@CR11]\]. These inflammatory species also have direct communication with the brain via self-produced neurotransmitters and the vagus nerve receptors in the gut, with mostly unknown significance \[[@CR12], [@CR13]\]. Probiotics or anti-inflammatory species, the most studied being the *Lactobacillus* and *Bifidobacteria*, can act to suppress this immune and sympathetic reaction. Demonstrations in both animal and human studies have shown that the administration of beneficial microbes can reduce both inflammation and anxiety or behavioral signs of distress \[[@CR14]--[@CR16]\]. These agents work on the same system but in a different location as chemical antidepressants, suggesting possibilities for a new "psychobiotic" class of low-side effect anti-inflammatory, anti-anxiety, and antidepressant.

The studies thus far are promising though small in scale and broad in scope. Rodent behavior \[[@CR17]\] and levels of anxiety are influenced by probiotics, prebiotics (types of fiber that act as food for the microbiome), and fecal transplants \[[@CR18]\]. In humans, decreased negative, ruminative thoughts have occurred in randomized controlled trials after a month on probiotics \[[@CR19]\], while prebiotics and the administration of pseudocommensals (microbial species that do not live in the gastrointestinal tract but due to presence in water and soil have had continuously passed through the human gut in evolutionary history) have decreased anxiety \[[@CR20], [@CR21]\]. The rates of ADHD or autistic spectrum disorders in young teenagers supplemented with probiotics as infants dropped to 0 % compared to controls in one fascinating study \[[@CR22]\]. In another paper, researchers were able to determine the patients with and without depression with 100 % sensitivity and 97 % specificity just by looking at the microbial genomes from fecal swabs \[[@CR23]\]. The administration of antibiotics with antidepressants had a significant effect on psychotic depression compared to antidepressants alone \[[@CR24]\] in a small group of inpatients. In addition, major differences have been found between the oral microbiome of people with schizophrenia vs. controls \[[@CR25]\], and, not surprisingly, the microbiome of people with anorexia is quite different during disease behavior than in recovery \[[@CR26]\]. Further studies postulate a role between but microbiota and Alzheimer's dementia \[[@CR27]\].

Having established there are some fascinating links between the microbiome and mental health, the challenges to finding safe, actionable clinical data are profound. One obvious obstacle is the sheer diversity of diagnoses of mental illness, ameliorated somewhat by the goal of addressing underlying systemic inflammation with microbiome manipulation. That goal may not be as simple as it sounds, given that the microbiome is a changeable entity reacting to local stress, food intake, sleep, and baseline conditions. One microbiome may be ideal for one person and not for another with a different diet or situation. One-size-fits-all probiotics may not show us the best clinical effect. A more bespoke approach based on microbiome sequencing and filling gaps of known guardian species such as *Bifidobacterium longum* and *Akkermnansia muciniphila* \[[@CR28]\] may be more effective. We need to also establish the benefit/risks of low vs. high-dose probiotic supplementation and the utility of giving prebiotic fibers and probiotics together.

Food intake is a massive confounder to any study of the microbiome. Numerous studies show more traditional, whole foods are superior for mental health \[[@CR29]\]. While optimal levels of vitamins, minerals, and certain fatty acids are key for brain functioning, these traditional diets also tend to be higher in certain fibers and prebiotics whose benefits for the microbiome could explain much of the effect of these diets on mental health \[[@CR30], [@CR31]\]. Clearly, we need to do more work and use the information from studies designed to more carefully discern the effects of diet, prebiotics, and probiotics on general health. Numerous one-off studies of various probiotic brands for mental disorders will leave us in a similar state to those trying to glean some wisdom from the research on omega 3 fatty acids, confused and underwhelmed.

In addition, attention must be paid to another long-term modifier of the immune system in human evolutionary history, ignored in many "psychobiotic" studies, the eukaryotic helminths \[[@CR32], [@CR33]\]. Humans have coevolved with helminthic infection for the entire evolutionary history of our species, and recent times are striking for their absence. Since the early 1900s such common infections such as hookworms and *Enterobius vermicularis* in the developed world have decreased tremendously \[[@CR34], [@CR35]\] with numerous possible downstream effects on long-term immunity and host behavior. Parasitic contribution falls alongside that of the commensal microbiome, and helminths deserve a chair at the table of microbiome research in mental health. Helminths have been used experimentally for treatment of autoimmune diseases such as Crohn's disease and multiple sclerosis \[[@CR36]\] with some interesting case reports of psychiatric disorders (including anxiety disorders, affective disorders, and autistic spectrum disorders) co-occuring with the autoimmune disease remitting as well \[[@CR37]\]. It would be prudent to study helminthic therapies for neuropsychiatric conditions, particularly in those conditions such as OCD or some types of psychosis where there is a suspected autoimmune contribution \[[@CR38], [@CR39]\].
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Microbiome manipulation is an evolving tool in the armamentarium to fight mental illness. We must temper enthusiasm and marketing of any particular probiotic strain or brand with a large helping of wisdom and experience already gleaned from the many researchers becoming experts in this relatively new field of human medicine. Multidisciplinary communication among medical researchers, anthropologists, and physiologists can help us to modulate our modern environment to ameliorate the need for psychobiotics in the first place.
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